EKF Diagnostics is a global medical manufacturer of point-of-care (POCT) devices and tests for hemoglobin, glycated hemoglobin (HbA1c), glucose and lactate. EKF also has a long history in clinical chemistry reagent manufacture in the USA.
During the COVID-19 pandemic EKF began the production of PrimeStore MTM under licence from Longhorn Vaccines and Diagnositcs in San Antonio, Texas. PrimeStore MTM is widely used in the US and Europe to neautralise viruses in patient samples.
EKF is also a distributor of the Kantaro COVID-SeroKlir antibody kits, a quantitative ELISA test. SeroKlir provides an antibody titer that determines the presence and volume of COVID-19 antibodies present in a patient.
EKF Point of Care (POC) analyzers are designed for use within doctors' surgeries, clinics, hopsitals and laboratories to provide fast and accurate results at an affordable price.
EKF Central Laboratory division manufactures a wide spectrum of reagents for use in hospital laboratories across a broad portfolio of automated and semi-automated analysers.
EKF Life Sciences specializes in producing enzymes and contracted custom products for use in medical diagnostics, pharmaceuticals and industry.
All EKF's facilities are accredited by the international standards agencies that oversee the design and manufacture of medical devices. EKF-diagnostic GmbH and Stanbio Laboratory are both FDA registered facilities, whilst Stanbio is also accredited by the Canadian Medical Devices Conformity Assessment Scheme (CMDCAS).
EKF is a global company with offices in the UK, Germany, USA, Russia and China and counts with a network of more than 200 distributors covering every country.
EKF Diagnostics Holdings plc is listed on the London Stock Exchange. For Investor Announcements, Company Information and background to the Board of Directors and Advisors visit the Investors section of this website.
Copyright © 2021 | Powered by Intergage